22 April 2009 -
Olink Bioscience and Eurogentec sign distribution agreement for Europe
Liège, Belgium, April 22, 2009.
UPPSALA, SWEDEN, April 6, 2009 – Olink Bioscience has signed an agreement with Eurogentec S.A. for distribution of the Duolink® in situ PLA product line in major geographies in Europe. Eurogentec, headquartered in Belgium, will handle distribution and sales for Germany, France, Belgium, Luxembourg, The Netherlands, Switzerland, Austria, and the Czech Republic. This region represents an important market for Olink Bioscience with a rapidly increasing number of academic and industrial customers. Eurogentec will become the sole distributor in the region.
“We are excited to have Eurogentec as our distributor in major geographies of Europe. With an excellent reputation as a provider of first class products and a strong sales organization, Eurogentec is in a perfect position to help us expand the market for our Duolink® product line in the region” says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience.
“The in situ PLA™ technology provided by Olink Bioscience represents a breakthrough in the proteomics field and we are very excited to be able to offer this new enabling tool to the research community in the European market. The Duolink® product line offers a significant commercial potential and we see great opportunities in this agreement”, adds Roberto Locigno, Product Manager for Proteomics at Eurogentec.
Duolink® enables researchers to study signalling pathways in native cells and tissue by making it possible to detect, localize, and quantify endogenous proteins and events. Duolink® is based on the proprietary in situ Proximity Ligation Assay (in situ PLA) technology from Olink Bioscience. The Duolink® product family extends the capabilities of traditional immuno-fluorescence and immunohistochemistry to include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity. Target proteins are detected with single molecule resolution, allowing digital quantification and information about the exact localization of the protein or event. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sections.
For more information about Duolink technology and kits, click here!
About Olink AB
Olink AB is a privately held biotech supply company based in Uppsala, Sweden founded in 2004. The company controls significant IP covering technologies related to detection and analysis of proteins and nucleic acids. These technologies are commercialized as proprietary Olink products, in spin-out companies and in collaboration with external organization. In 2007 Olink Bioscience introduced the Duolink® products for in situ detection of proteins, protein interactions and protein modifications. These products are based on Proximity Ligation Assays (PLA) technology which use dual recognition of the analyte in combination with a DNA amplification based reporter system, resulting in unparalleled sensitivity and specificity. Duolink® products enable detection of single molecular events in fixed cells and tissue. The technology is available as reagent kits and contract research projects through Olink Bioscience.
Duolink® is intended for research use only. Duolink® is not for use in human diagnostic or therapeutic procedures.
About Eurogentec
Eurogentec is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. Experts in small- and large-scale DNA, RNA and peptide synthesis, Eurogentec is an experienced Contract Manufacturing Organization (CMO), and is fully ISO 9001 and ISO 13485:2003 certified. It operates two full-service, state-of-the-art GMP-compliant manufacturing facilities that provide high-value custom biologics and a wide range of oligonucleotide-based components for diagnostic and therapeutic applications. Eurogentec’s products are manufactured to meet or exceed the highest US and European regulatory requirements. Eurogentec is comprised of three inter-related business units:
- Life Science Research Products
- Diagnostic & Therapeutic Products & Services (GMP)
- Biologics Services (GMP)
Eurogentec S.A. is a privately held company headquartered in Liège, Belgium and has subsidiaries in North America, France, Germany, the UK, the Netherlands and Switzerland and additional production facilities in Japan and Singapore. Eurogentec employs 350 people globally.
For information please contact:
Peter Karlberg, Director Sales and Marketing
Olink Bioscience
Phone: +46 (0)18 444 30 70
email: peter.karlberg@olink.com |
Pierre Lacaze, Director Sales and Marketing
Eurogentec S.A.
Phone: +32(0)4 372 74 00
email: p.lacaze@eurogentec.com |
Back to news list
|